OmniVision Integrated Circuits Group, Inc. (0501.HK) has launched its Hong Kong IPO, with the offering period running from December 31, 2025, to January 7, 2026. The company plans to issue 45,800,000 H-shares globally, with an over-allotment option of 15%. The maximum issue price is HKD 104.80 per share, with a minimum subscription of 100 shares, and the entry fee is approximately HKD 10,585.69. The shares are expected to begin trading on the Main Board of the Hong Kong Stock Exchange on January 12, 2026. Joint bookrunners include UBS, CICC, PASCHK, and GF Securities.
Issue Ratio: Approximately 10% for the Hong Kong public offering (4,580,000 H-shares, subject to reallocation) and approximately 90% for international placement (41,220,000 H-shares, subject to reallocation).
Issue Price: Maximum of HKD 104.80 per share.
Offer Period: From December 31, 2025, to January 7, 2026.
Listing Date: January 12, 2026 (Monday).
IPO Sponsors: UBS, CICC, PASCHK, GF Securities.

OmniVision is a global fabless semiconductor design company, with CMOS image sensors (CIS) as its main product. The company focuses on image sensor solutions, display solutions, and analog solutions, serving industries such as smartphones, automotive, healthcare, security, and emerging markets. According to a report by Frost & Sullivan, OmniVision is the world's third-largest digital image sensor supplier by revenue from image sensor solutions, with a market share of 13.7% in 2024. The company follows the fabless model, specializing in design and sales, while collaborating with global leading wafer foundries for manufacturing.
According to the prospectus, OmniVision’s revenues were approximately RMB 20.04 billion, RMB 20.98 billion, and RMB 25.71 billion in 2022, 2023, and 2024, respectively. During the same period, net profits were approximately RMB 951 million, RMB 544 million, and RMB 3.28 billion, respectively. In the first half of 2025, the company generated revenue of approximately RMB 13.94 billion and net profit of about RMB 2.02 billion. Assuming the maximum issue price of HKD 104.80 per share and no over-allotment, the company expects to raise a net amount of approximately HKD 4.693 billion. The funds will be allocated as follows: 70% (about HKD 3.29 billion) for investment in key technology research and development, 10% (about HKD 469.3 million) for market penetration and business expansion, 10% (about HKD 469.3 million) for strategic investments and/or acquisitions, and 10% (about HKD 469.3 million) for working capital and general corporate purposes.
Margin subscription: 0 % interest, leverage up to 10×
Cash subscription: HK$0 handling fee
Grey-market trading supported
* 0 % interest applies to margin subscription amounts of HK$20 million or below.
^ All handling fees are waived for cash subscriptions.
This promotion is effective from 5 December 2025 until further notice. Certain high-profile IPOs may be excluded. The actual interest rates and fees charged are those shown in the uSMART App subscription interface; statutory government and exchange levies will still apply. The company reserves the right to amend, suspend or terminate the above offer or its terms and conditions at any time without prior notice, and its interpretation shall be final.
The uSMART HK App features an IPO Centre with exclusive perks, allowing clients to subscribe instantly to public offerings. After logging into the app, tap "Trade" at the bottom-right, go to "IPO Subscription," select OmniVision, tap "Public Offer," enter your subscription quantity, and submit your order.

(Image source: uSMART HK App)
